Can pregnant women take Sudafed (pseudoephedrine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sudafed (Pseudoephedrine) Use in Pregnancy

Pregnant women should avoid Sudafed (pseudoephedrine) during the first trimester due to potential associations with vascular disruption birth defects, but may use it cautiously in the second and third trimesters if safer alternatives have failed and the maternal benefit clearly outweighs the risk.

First Trimester: Avoid Pseudoephedrine

  • Oral decongestants including pseudoephedrine should be avoided during the first trimester because of conflicting reports linking them to congenital malformations such as gastroschisis and small intestinal atresia 1, 2.

  • The risk appears to increase further when decongestants are combined with acetaminophen or salicylates 1, 2.

  • While a recent large cohort study (251,543 pregnancies) found no increased risk of major congenital malformations with first-trimester pseudoephedrine exposure 3, guideline recommendations from the Journal of Allergy and Clinical Immunology take precedence and advise avoidance during organogenesis 1.

Safer Alternatives to Consider First

Non-Pharmacologic Options

  • Start with nasal saline rinses as the first-line approach before any medication 2.

Pharmacologic Alternatives (in order of preference)

  • Intranasal corticosteroids (particularly budesonide) are preferred over oral decongestants, with much lower systemic exposure and established safety data 2.

  • Second-generation antihistamines like cetirizine have extensive safety data from large birth registries and cohort studies confirming first-trimester safety 4, 2.

  • Topical intranasal decongestants used short-term may have a better safety profile than oral agents, though data are limited 2.

Second and Third Trimester: Use with Caution

  • If pseudoephedrine is necessary after the first trimester, use the lowest effective dose for the shortest duration 5.

  • A single 60-mg dose of pseudoephedrine in the third trimester did not significantly alter uterine or fetal blood flow in healthy pregnant women 6.

  • The FDA drug label advises pregnant women to "ask a health professional before use" 7.

Clinical Decision Algorithm

For any trimester:

  1. Begin with nasal saline rinses 2
  2. Add intranasal corticosteroids (budesonide preferred) if symptoms persist 2
  3. Consider adding cetirizine for additional symptom control 2
  4. Only use pseudoephedrine if the above measures fail AND only after the first trimester 1, 2

Important Caveats

  • Avoid combination products that include pseudoephedrine with acetaminophen or other medications, as these carry additional risks 1, 2.

  • The vasoconstrictive effects of pseudoephedrine raise theoretical concerns about vascular disruption defects, particularly in women who also smoke 8.

  • Discontinue use if symptoms do not improve within 7 days or if nervousness, dizziness, or sleeplessness occur 7.

  • Women with heart disease, hypertension, thyroid disease, diabetes, or enlarged prostate should consult their physician before use 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pseudoephedrine Use in Pregnancy: Safety and Alternatives

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Antihistamine Use in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Over-the-counter medications in pregnancy.

American family physician, 2003

Research

Teratogen update: pseudoephedrine.

Birth defects research. Part A, Clinical and molecular teratology, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.